392 related articles for article (PubMed ID: 31139863)
41. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
42. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
[TBL] [Abstract][Full Text] [Related]
43. Activation of the miR-34a/SIRT1/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs.
Tian XF; Ji FJ; Zang HL; Cao H
PLoS One; 2016; 11(7):e0158657. PubMed ID: 27387128
[TBL] [Abstract][Full Text] [Related]
44. Vitamin K2 Alleviates Insulin Resistance in Skeletal Muscle by Improving Mitochondrial Function
Su X; Wang W; Fang C; Ni C; Zhou J; Wang X; Zhang L; Xu X; Cao R; Lang H; Wang F
Antioxid Redox Signal; 2021 Jan; 34(2):99-117. PubMed ID: 32253917
[No Abstract] [Full Text] [Related]
45. GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway.
Wang Y; Zeng Z; Guan L; Ao R
J Cell Mol Med; 2020 Jun; 24(11):6107-6119. PubMed ID: 32324317
[TBL] [Abstract][Full Text] [Related]
46. Carbon monoxide protects against hepatic ischemia/reperfusion injury by modulating the miR-34a/SIRT1 pathway.
Kim HJ; Joe Y; Yu JK; Chen Y; Jeong SO; Mani N; Cho GJ; Pae HO; Ryter SW; Chung HT
Biochim Biophys Acta; 2015 Jul; 1852(7):1550-9. PubMed ID: 25916635
[TBL] [Abstract][Full Text] [Related]
47. P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1.
Li Q; Kim YR; Vikram A; Kumar S; Kassan M; Gabani M; Lee SK; Jacobs JS; Irani K
Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2394-2403. PubMed ID: 27789474
[TBL] [Abstract][Full Text] [Related]
48. MicroRNA-34a targets sirtuin 1 and leads to diabetes-induced testicular apoptotic cell death.
Jiao D; Zhang H; Jiang Z; Huang W; Liu Z; Wang Z; Wang Y; Wu H
J Mol Med (Berl); 2018 Sep; 96(9):939-949. PubMed ID: 30030567
[TBL] [Abstract][Full Text] [Related]
49. Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling.
Zou Y; Chen Z; Sun C; Yang D; Zhou Z; Peng X; Zheng L; Tang C
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681600
[TBL] [Abstract][Full Text] [Related]
50. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
[TBL] [Abstract][Full Text] [Related]
51. 11β-HSD1 Inhibitor Alleviates Non-Alcoholic Fatty Liver Disease by Activating the AMPK/SIRT1 Signaling Pathway.
Chen Y; Li J; Zhang M; Yang W; Qin W; Zheng Q; Chu Y; Wu Y; Wu D; Yuan X
Nutrients; 2022 Jun; 14(11):. PubMed ID: 35684158
[TBL] [Abstract][Full Text] [Related]
52. 1,25-Dihydroxyvitamin D Decreases Tertiary Butyl-Hydrogen Peroxide-Induced Oxidative Stress and Increases AMPK/SIRT1 Activation in C2C12 Muscle Cells.
Chang E
Molecules; 2019 Oct; 24(21):. PubMed ID: 31671915
[TBL] [Abstract][Full Text] [Related]
53. Si-Ni-San Reduces Hepatic Lipid Deposition in Rats with Metabolic Associated Fatty Liver Disease by AMPK/SIRT1 Pathway.
Zhang N; Liu T; Wang J; Xiao Y; Zhang Y; Dai J; Ma Z; Ma D
Drug Des Devel Ther; 2023; 17():3047-3060. PubMed ID: 37808345
[TBL] [Abstract][Full Text] [Related]
54. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
55. Celastrol attenuates inflammatory responses in adipose tissues and improves skeletal muscle mitochondrial functions in high fat diet-induced obese rats via upregulation of AMPK/SIRT1 signaling pathways.
Abu Bakar MH; Shariff KA; Tan JS; Lee LK
Eur J Pharmacol; 2020 Sep; 883():173371. PubMed ID: 32712089
[TBL] [Abstract][Full Text] [Related]
56. Sesamol Reverses Myofiber-Type Conversion in Obese States via Activating the SIRT1/AMPK Signal Pathway.
Hu MM; Zheng WY; Cheng MH; Song ZY; Shaukat H; Atta M; Qin H
J Agric Food Chem; 2022 Feb; 70(7):2253-2264. PubMed ID: 35166533
[TBL] [Abstract][Full Text] [Related]
57. Demethyleneberberine attenuates non-alcoholic fatty liver disease with activation of AMPK and inhibition of oxidative stress.
Qiang X; Xu L; Zhang M; Zhang P; Wang Y; Wang Y; Zhao Z; Chen H; Liu X; Zhang Y
Biochem Biophys Res Commun; 2016 Apr; 472(4):603-9. PubMed ID: 26970305
[TBL] [Abstract][Full Text] [Related]
58. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
Ao R; Wang Y; Tong J; Wang BF
Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
[TBL] [Abstract][Full Text] [Related]
59. The MicroRNA miR-696 is regulated by SNARK and reduces mitochondrial activity in mouse skeletal muscle through Pgc1α inhibition.
Queiroz AL; Lessard SJ; Ouchida AT; Araujo HN; Gonçalves DA; Simões Fróes Guimarães DSP; Teodoro BG; So K; Espreafico EM; Hirshman MF; Alberici LC; Kettelhut IDC; Goodyear LJ; Silveira LR
Mol Metab; 2021 Sep; 51():101226. PubMed ID: 33812060
[TBL] [Abstract][Full Text] [Related]
60. MicroRNA regulation of AMPK in nonalcoholic fatty liver disease.
Sun H; Kemper JK
Exp Mol Med; 2023 Sep; 55(9):1974-1981. PubMed ID: 37653034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
